Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Struikmans

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The New England Journal of Medicine|July 23, 2015
Internal Mammary and Medial Supraclavicular Irradiation in Breast CancerPhilip M Poortmans, Sandra Collette, Carine Kirkove, et al.
The Lancet. Oncology|November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trialPhilip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapiesOrit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
JAMA Oncology|September 9, 2016
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical TrialConny Vrieling, Erik van Werkhoven, Philippe Maingon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
CA: a Cancer Journal for Clinicians|May 16, 2026
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
The Lancet. Oncology|June 29, 2026
Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The New England Journal of Medicine|July 23, 2015
Internal Mammary and Medial Supraclavicular Irradiation in Breast CancerPhilip M Poortmans, Sandra Collette, Carine Kirkove, et al.
The Lancet. Oncology|November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trialPhilip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapiesOrit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
JAMA Oncology|September 9, 2016
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical TrialConny Vrieling, Erik van Werkhoven, Philippe Maingon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
CA: a Cancer Journal for Clinicians|May 16, 2026
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
The Lancet. Oncology|June 29, 2026
Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
Pageof 7